海外招聘者

	H. Phillip Koeffler （Cancer Science Institute of Singapore, National University of Singapore, Singapore/National University Cancer Institute of Singapore, National University Hospital, Singapore/Cedars-Sinai Medical Center, Los Angeles, USA） Special Lecture “Evolution of the term preleukemia”
	Kenneth C. Anderson （Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA） ASH Special Lecture “New insights into therapeutic targets in multiple myeloma”
	Pieter Sonneveld （Professor of Hematology, Erasmus MC Rotterdam, The Netherlands） EHA Special Lecture “New therapeutic developments in multiple myeloma”
	Scott A. Armstrong （Dana-Farber Cancer Institute, Boston, MA, USA） JSH-ASH Joint Symposium（Symposium 7）： New insights into AML biology “Targeting epigenetic mechanisms to reverse leukemia stem cell gene expression”
	John E. Dick （Princess Margaret Cancer Centre and University of Toronto, Canada） JSH-ASH Joint Symposium（Symposium 7）： New insights into AML biology “Leukemia stem cells play a central role in therapy failure and disease recurrence in human AML”
	Henk M. Lokhorst （VU University Medical Center, Amsterdam, The Netherlands） JSH-EHA Joint Symposium（Symposium 5）： Novel treatment strategy for MM using novel drugs in combination with immune modulation “Clinical application of Daratumumab for myeloma”
	Hermann Einsele （Haematology and Oncology, University Hospital Wüerzburg, Germany） JSH-EHA Joint Symposium（Symposium 5）： Novel treatment strategy for MM using novel drugs in combination with immune modulation “Basic and clinical research on PD-1/PD-L1 in multiple myeloma”
	Hara Prasad Pati （Dept. of Hematology, All India Institute of Medical Sciences, New Delhi, India） Asian Joint Panel Discussion： MDS/MPN: Progress of basic and clinical research in Asia “Spectrum & flowcytometry study in primary MDS”
	Noppadol Siritanaratkul （Division of Hematology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand） Asian Joint Panel Discussion： MDS/MPN: Progress of basic and clinical research in Asia “Incidence and characteristics of polycythemia Vera, essential thrombocythemia and primary myelofibrosis in Thailand: A patient cohort in the tertiary care hospital”
	Ken-Hong Lim （Division of Hematology and Oncology, MacKay Memorial Hospital, Taipei, Taiwan/Department of Medicine, MacKay Medical College, New Taipei City, Taiwan） Asian Joint Panel Discussion： MDS/MPN: Progress of basic and clinical research in Asia “B cell immune profiles in essential thrombocythemia”
	Thuan Heng Charles Chuah （Department of Haematology, Singapore General Hospital, Singapore/Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore） Asian Joint Panel Discussion： MDS/MPN: Progress of basic and clinical research in Asia “Asian CML: How different is it from the West?”
	Qian Jiang （Peking University People's Hospital, Peking University Institute of Hematology, China） Asian Joint Panel Discussion： MDS/MPN: Progress of basic and clinical research in Asia “Patient-reported outcomes in patients with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy in China”
	Dong-Wook Kim （Hematology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea） Asian Joint Panel Discussion： MDS/MPN: Progress of basic and clinical research in Asia “The future prospects for treatment free remission in CML”
	Christian G. Steidl （Lymphoid Cancer Research, BC Cancer Agency, Vancouver, Canada/Pathology, University of British Columbia, Vancouver, Canada） Symposium 1： Control of immune microenvironment in tumor “The tumor microenvironment in B cell lymphomas”
	Suthat Fucharoen （Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Salaya Campus, Nakornpathom, Thailand） Symposium 2： Anemia and ineffective erythropoiesis “Hemoglobinopathy in Southeast Asia”
	Clara Camaschella （Vita Salute University and San Raffaele Scientific Institute, Milano, Italy） Symposium 2： Anemia and ineffective erythropoiesis “The role of iron in ineffective erythropoiesis”
	Wyndham Wilson （National Cancer Institute, USA） Symposium 4： Cutting-edge of basic and clinical research for malignant lymphoma “Advances in the targeted treatment of diffuse large B cell lymphoma”
	Andreas Engert （University Hospital of Cologne, Cologne, Germany） Symposium 4： Cutting-edge of basic and clinical research for malignant lymphoma “New horizons in the treatment of Hodgkin lymphoma”
	Andres Hidalgo （Fundación CNIC, Madrid, Spain/Institute for Cardiovascular Prevention, Munich, Germany） Symposium 6： New world of innate immunity: Novel ontogeny and functions “Innate immune networks as regulators of the hematopoietic niche”
	Frederic Geissmann （Immunology, Memorial Sloan Kettering Cancer Center, New York, NY, USA） Symposium 6： New world of innate immunity: Novel ontogeny and functions “Development and functions of resident macrophages”
	Elli Papaemmanuil （Memorial Sloan Kettering Cancer Center, USA） Symposium 9： Myeloid neoplasia and clinical sequence “Translating recent cancer genome discoveries to patient tailored clinical intervention protocols”
	Rafael Bejar （Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, USA） Symposium 9： Myeloid neoplasia and clinical sequence “Clinical implications of clonal hematopoiesis”
	Effie Wang Petersdorf （Fred Hutchinson Cancer Research Center, Seattle, WA, USA） Symposium 10： GVHD: A bench-to-bedside update “Immunogenetics of unrelated donor hematopoietic cell transplantation”
	Nicolaus Kröger （Stem Cell Transplantation, University Medical Center, Hamburg, Germany） Symposium 10： GVHD: A bench-to-bedside update “ATG for prevention of chronic GvHD after allogeneic stem cell transplantation
	Shaji Kumar （Mayo Clinic, USA） Special Educational Lecture 1-4 “Novel therapeutic strategies for multiple myeloma”
	Steven M. Horwitz （Memorial Sloan Kettering Cancer Center, USA） Special Educational Lecture 1-8 “Therapeutic approach for T-cell lymphoma”
	Steven P. Treon （Dana-Farber Cancer Institute, Boston, MA, USA） Special Educational Lecture 1-15 “Genomic basis and treatment of Waldenstrom's macroglobulinemia”
	Stephen D. Nimer （Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, USA） Special Educational Lecture 2-12 “MDS stem cell behavior: Can it predict clinical outcomes?”
	Christine Chomienne （Institut Universitaire d'Hematologie, Hopital Saint Louis, France） Special Educational Lecture 3-7 “Acute Promyelocytic leukemia: A model of personalized medicine”